In this file
The homepage contains different price figures that need reconciliation before checkout. That detail matters when comparing the proposed prescription, payment schedule, and access to help.
This provider file follows the company’s published material and the questions it leaves open. It covers the care arrangement, price, cancellation boundaries, and contact routes; it does not certify the business or determine whether a treatment is appropriate for a particular person.
Understand the care arrangement
Blue Haven RX describes questionnaire-based evaluation, medical support, and medication shipped through a pharmacy partner. It places product cards and an FAQ on the same page. Reading both matters because their figures do not present one unambiguous ongoing price.
Name the organizations involved in your own plan. The website operator, clinical practice, and pharmacy may be separate businesses. A patient should know which one is responsible for a medical decision, which holds the account, and which handles the medication.
Read the price in its proper context
Product cards show compounded semaglutide at $149 and tirzepatide at $179 per month, while the FAQ states $179 and $259 respectively. The page also references a three-month offer. We cannot determine from those figures alone which amount applies to a new patient or renewal; obtain a dated quote with the full term.
Record the total paid today, the period it buys, and the next payment. If a figure is expressed per month but collected for several months, keep both numbers in the comparison. Our price-comparison worksheet helps separate a low initial figure from the continuing commitment.
Find the cancellation boundary
The service publishes subscription and terms information, but an unresolved price difference should be settled before authorizing recurring charges. Ask which offer controls, when the next payment occurs, and what happens if the prescription changes during a purchased period. Save the quote as well as the accepted agreement.
A useful request names the next renewal and the current order separately. Ask for confirmation of both the effective cancellation date and the pharmacy status. Instructions for stopping or changing the medicine itself need to come from the treating professional.
Identify the actual prescription
The product cards explicitly identify compounded semaglutide and tirzepatide. The page’s pharmacy-partner description is not a substitute for the name on a patient’s prescription label. Ask for the assigned dispenser and relevant instructions; the appearance of a medication in an advertisement does not identify the shipped formulation.
FDA approval concerns a particular drug product. A compounded preparation has not received that approval, and evidence for a different formulation cannot guarantee an individual result. Read the product-approval explanation and ask questions about the exact medicine proposed.
Contact and account help
Blue Haven RX’s published contact number is (310) 744-1417. The documented email route is support@bluehavenrx.com.
Ask support to reconcile the differing homepage and FAQ prices in writing.
Start from the official Blue Haven RX website to find its verified patient-account navigation. We have not signed into a private portal or measured its support response. Do not share passwords, access codes, payment-card details, or medical records with a review site.
Bring one concrete question to the consultation
Which of the two published price sets applies to me, and what amount will be charged when the initial offer ends?
Write the answer beside the proposed prescription and agreement. If it describes a different product, an expired promotion, or a plan you are not eligible for, ask for clarification. Our pre-purchase checklist can help keep those questions organized.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- Terms of Service – Blue Haven RX ↗Provider-published information · Checked September 22, 2026
- Blue Haven RX ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026